Differential binding of bacterial lipopolysaccharide to bovine peripheral-blood leukocytes
- PMID: 8432562
- DOI: 10.1007/BF00916391
Differential binding of bacterial lipopolysaccharide to bovine peripheral-blood leukocytes
Abstract
The response of mammalian monocytes and macrophages to bacterial lipopolysaccharide (LPS) may be influenced by serum factors that increase or decrease the propensity of LPS to bind to cell surfaces. We used fluorescence flow cytometric analysis to investigate the capability of bovine peripheral-blood leukocytes to bind LPS in the presence or absence of bovine serum. At all concentrations of FITC-LPS tested (LPS from E. coli 0111:B4; 10 ng/ml, 100 ng/ml, 1 micrograms/ml), monocytes, lymphocytes, and granulocytes bound more FITC-LPS in the presence of 10% bovine serum than in serum-free conditions (P < 0.01). At the intermediate concentration tested (100 ng/ml), monocytes displayed a relative fluorescence intensity (RFI) of 2.27 +/- 1.24 units without serum and 17.48 +/- 8.05 with 10% serum. Values for granulocytes were similar to those of monocytes, 3.55 +/- 1.31 without and 19.24 +/- 6.93 with serum, and values for lymphocytes were 1.89 +/- 0.47 RFI units without serum and 6.27 +/- 2.61 RFI units with serum. At 10 ng/ml and 1 microgram/ml FITC-LPS the RFI of monocytes and granulocytes were also similar and not significantly different, and both bound significantly more LPS than lymphocytes (P < 0.01). When 100 ng/ml FITC-LPS was coincubated with leukocytes, 10% serum, and a 100-fold excess of unlabeled LPS, the amount of FITC-LPS bound to monocytes was reduced from 23.99 to 7.23 RFI units (P < 0.01), reduced from 22.00 to 7.30 RFI units with granulocytes (P < 0.05), and reduced from 7.51 to 2.29 RFI units (P < 0.10) with lymphocytes. These data demonstrate that factors in bovine serum significantly amplify the association of LPS with peripheral-blood leukocytes and that increased binding of LPS is greatest with monocytes and granulocytes.
Similar articles
-
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.J Immunol. 1990 Jul 1;145(1):318-24. J Immunol. 1990. PMID: 2162891
-
Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragment.Cytometry. 1996 Jan 1;23(1):59-66. doi: 10.1002/(SICI)1097-0320(19960101)23:1<59::AID-CYTO9>3.0.CO;2-H. Cytometry. 1996. PMID: 14650442
-
Lipopolysaccharide-binding factors are present in bovine serum.Biofactors. 1992 Dec;4(1):33-6. Biofactors. 1992. PMID: 1292474
-
Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.Eur J Immunol. 1997 Dec;27(12):3303-9. doi: 10.1002/eji.1830271229. Eur J Immunol. 1997. PMID: 9464818
-
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.Infect Immun. 1997 Jun;65(6):2272-7. doi: 10.1128/iai.65.6.2272-2277.1997. Infect Immun. 1997. PMID: 9169763 Free PMC article.
Cited by
-
Anti-inflammatory and Anti-oxidative Effects of Phytohustil® and Root Extract of Althaea officinalis L. on Macrophages in vitro.Front Pharmacol. 2020 Mar 17;11:290. doi: 10.3389/fphar.2020.00290. eCollection 2020. Front Pharmacol. 2020. PMID: 32256361 Free PMC article.
-
Signal transduction pathways of bacterial lipopolysaccharide-stimulated bovine vascular endothelial cells.Inflammation. 1994 Apr;18(2):221-33. doi: 10.1007/BF01534563. Inflammation. 1994. PMID: 8070906
-
CD14 and tissue factor expression by bacterial lipopolysaccharide-stimulated bovine alveolar macrophages in vitro.Infect Immun. 1995 Jan;63(1):51-6. doi: 10.1128/iai.63.1.51-56.1995. Infect Immun. 1995. PMID: 7528735 Free PMC article.
-
Krill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro.Mar Drugs. 2017 Mar 15;15(3):74. doi: 10.3390/md15030074. Mar Drugs. 2017. PMID: 28294970 Free PMC article.